HEAD & NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD & NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD & NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple supplement tame immunotherapy side effects in head and neck cancer?
Disease control Recruiting nowThis study is for people with advanced head and neck cancer who are starting a standard immunotherapy drug called pembrolizumab. Researchers want to see if adding a special supplement called a postbiotic can reduce side effects and improve how the body responds to treatment. Abou…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis phase 3 trial tests a new treatment for people with high-risk head and neck cancer who cannot receive the standard chemotherapy drug cisplatin. Participants receive radiation therapy combined with two drugs (nimotuzumab and benmelstobart) to see if this approach improves dis…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New combo therapy offers hope for head and neck cancer patients who can't have chemo
Disease control Recruiting nowThis study tests whether adding the targeted drug nimotuzumab to standard radiation therapy helps control advanced head and neck cancer better than radiation alone. It is for 335 adults whose cancer has spread locally but who cannot take platinum-based chemotherapy. The main goal…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New PET scan could end guesswork after head and neck cancer radiation
Diagnosis Recruiting nowThis study is testing a new type of PET scan to see if it can tell the difference between cancer that is still there and swelling caused by radiation treatment in people with head and neck cancer. About 180 adults who finished radiation therapy will get this special scan 3 months…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 15, 2026 19:02 UTC
-
Smart radiotherapy aims to cut cancer treatment side effects
Symptom relief Recruiting nowThis study tests a new way to give radiation for head and neck cancer. Instead of a fixed plan, the radiation is adjusted daily to match changes in the patient's body. The goal is to lower side effects like trouble swallowing and dry mouth. About 40 adults with throat or voice-bo…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 16, 2026 23:36 UTC
-
PET scans may predict immunotherapy success in head and neck cancer
Knowledge-focused Recruiting nowThis study is looking at whether a special PET scan taken 6 weeks after starting immunotherapy can predict how well the treatment will work at 3, 6, and 9 months. It involves 25 adults with advanced head and neck cancer that has come back or spread. The goal is to see if early ch…
Matched conditions: HEAD & NECK SQUAMOUS CELL CARCINOMA
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Jun 16, 2026 23:36 UTC